PRINCIPAL TECHNOLOGIES FINAL REBRAND AND STRENGTHENS ADVISORY BOARD

PRINCIPAL TECHNOLOGIES FINAL REBRAND AND STRENGTHENS ADVISORY BOARD

Principal Technologies Inc. (the " Company " or " Principal ") (TSXV: PTEC.P), a healthcare technologies investor, is pleased to provide a corporate update to shareholders and also announces that it has updated and upgraded its website ( www.principal-technologies.com ) to better reflect the strategic focus of the Company.

Principal's focus is to capitalize on arbitrage situations by acquiring healthcare technology companies with proven and leading technologies in the European Union (" EU "), expanding sales globally and taking advantage of the higher valuations in North America .

The Company plans to acquire a substantial private healthcare technology company within 12 months which will transform Principal and provide a platform for future growth and profitability.

The Company has access to both acquisition targets and significant EU capital through its high profile management team and advisors. Key people include:

Jerry Trent – President, CEO Chief Executive Officer and Director
Mr. Trent is the founder of Trent Investments, a multi-family direct investment agency for European ultra-high net-worth individuals and asset management funds. In Europe , he served as the head of global markets and investment banking at SberBank, as well as the head of M&A, and member of the Global Deals Origination Group at PricewaterhouseCoopers. Mr. Trent's experience also includes being a successful Wall Street investor and portfolio manager.

Prince Alfred of Liechtenstein – Chairman, Board of Directors
Prince Alfred of Liechtenstein has served on numerous boards and in several supervisory positions, including at LGT Group (the largest family-owned asset management group globally). He holds a master's degree in economics and informatics and has authored numerous books and articles on a wide range of topics. Prince Alfred is also the Chairman of the advisory board of the International Peace Foundation, of which 19 advisors are Nobel Prize Laureates, including four in the medical field. His Serene Highness has also received multiple awards and prizes for his healthcare initiatives and humanitarian activity.

Dr. Leopold Specht - Director
Dr. Specht is a veteran attorney with extensive investment experience. He is the owner of international corporate law firm Specht & Partner. In addition to serving on numerous boards, he is a member of the Economic Council at Harvard Institute for Global Law at Harvard Law School. Widely renowned for his expertise, Dr. Specht regularly serves as a guest lecturer at institutions such as Harvard University , Brown University , the University of Turin , and the University of Sapienza Rome .

Dr. Gerald Rainer - Chairman, Board of Advisors
Dr. Rainer is the former CEO of Julius Baer , a USD$400 billion asset management company in Switzerland . He has also served as a board member and trustee of several large international organizations. His impressive business acumen and extensive international network have allowed him to also thrive as a serial entrepreneur.

Dr. Ivo Ivanovski - Board of Advisors
Dr. Ivanovski served as the IT Minister of the Republic of Macedonia from 2006 to 2015. He then entered the private sector as head of mergers and acquisitions, international affairs and regulations at A1 Telekom Austria Group, where he now serves as the CEO of the exchange-listed Tower Co. Dr. Ivanovski has received multiple awards over the course of his career, including the International Telecommunication Union's Distinguished Silver Star Award and an Honorary Doctorate for Technology Leadership.

Rick Geoffrion - Board of Advisors
Mr. Geoffrion has been president and CEO of multiple healthcare technology companies that have developed proprietary systems to significantly improve patient outcomes. Over the course of his 35-year career, Mr. Geoffrion has also served in board positions at numerous healthcare technology companies. Currently, he is vice-chairman of the Mullings Group, a leading career development firm focused on the healthcare sector.

Peter McKeown - CFO
A seasoned finance and business professional, Mr. McKeown has founded and served in executive positions at multiple successful Canadian public companies. Armed with decades of experience, Peter is a serial entrepreneur focused on the technology and resource sectors. He is a CPA and obtained a B.Comm from Carleton University .

The Company has made a few strategic acquisitions to date, primarily made to provide a technical due diligence team based in the EU and also to substantiate the valuation model.

E&E CRO Consulting GmbH (" E&E ")
An 80-percent-owned clinical research organization, E&E facilitates the international distribution permits process for healthcare technology companies. This strategic investment will allow Principal to build a unique database which it will leverage to improve patient outcomes, serve the industry (hospitals, insurers and other stakeholders seeking medical information), as well as find new acquisition targets for its international rollout process. Based in the EU, E&E is a cash-flow-positive company with stable revenue and a highly experienced in-house technical due diligence team.

Vision Surgery AI (" Vision ")
A minor equity investment with the capacity for expanded ownership as operations increase, Vision uses advanced computer vision and artificial intelligence technology for real-time monitoring of surgical teams and operating room equipment. Its technology detects and sends alerts about any anomaly or deviation from typical surgical procedures, significantly reducing complications and fatalities. Vision's technology also leverages collected observations to build a database of medical information for machine learning purposes. Given that roughly 80 percent of surgical fatalities stem from human error, Vision has the potential to considerably improve surgical outcomes.

The Company is now fully operational and pursuing its strategic focus. In the next 12 months it plans to acquire a substantial private healthcare technology company which will transform Principal and provide a platform for future growth and profitability.

ON BEHALF OF THE BOARD

"Jerry Trent"

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements:

This press release contains "forward-looking information" and "forward-looking statements" within the meaning of applicable securities laws. This information and statements address future activities, events, plans, developments and projections. All statements, other than statements of historical fact, constitute forward-looking statements or forward-looking information. Such forward-looking information and statements are frequently identified by words such as "may," "will," "should," "anticipate," "plan," "expect," "believe," "estimate," "intend" and similar terminology, and reflect assumptions, estimates, opinions and analysis made by management of the Company in light of its experience, current conditions, expectations of future developments and other factors which it believes to be reasonable and relevant. Forward-looking information and statements involve known and unknown risks and uncertainties that may cause the Company's actual results, performance and achievements to differ materially from those expressed or implied by the forward-looking information and statements and accordingly, undue reliance should not be placed thereon.

Risks and uncertainties that may cause actual results to vary include but are not limited to the availability of financing; fluctuations in commodity prices; changes to and compliance with applicable laws and regulations, including environmental laws and obtaining requisite permits; political, economic and other risks; as well as other risks and uncertainties which are more fully described in our annual and quarterly Management's Discussion and Analysis and in other filings made by us with Canadian securities regulatory authorities and available at www.sedar.com . The Company disclaims any obligation to update or revise any forward-looking information or statements except as may be required.

SOURCE Principal Technologies Inc.

Cision View original content: https://www.newswire.ca/en/releases/archive/August2023/22/c9485.html

News Provided by Canada Newswire via QuoteMedia

PTEC:CC
Principal Technologies

Principal Technologies Investor Kit

  • Corporate info
  • Insights
  • Growth strategies
  • Upcoming projects

GET YOUR FREE INVESTOR KIT

The Conversation (0)
Principal Technologies (TSXV:PTEC)

Principal Technologies


Keep reading...Show less
PRINCIPAL TECHNOLOGIES ANNOUNCES LOAN FINANCING AND PRIVATE PLACEMENT AND PROVIDES UPDATE ON VIVOSTAT A/S ACQUISITION

PRINCIPAL TECHNOLOGIES ANNOUNCES LOAN FINANCING AND PRIVATE PLACEMENT AND PROVIDES UPDATE ON VIVOSTAT A/S ACQUISITION

/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES /

Principal Technologies Inc. (the " Company ") (TSXV: PTEC) (FSE: J07), is pleased to announce that on March 8, 2024 it entered into a binding commitment letter with the effect that the GreenIslands Opportunities Fund (the " Lender ") will provide a secured loan in the principal amount of €8,000,000 (the " Loan ") to provide acquisition financing with respect to the cash portion of the purchase price for Vivostat AS (" Vivostat "), as further outlined in its news release dated February 6, 2024 and for general working capital purposes.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
PRINCIPAL TECHNOLOGIES ANNOUNCES FUNDAMENTAL ACQUISITION OF VIVOSTAT A/S

PRINCIPAL TECHNOLOGIES ANNOUNCES FUNDAMENTAL ACQUISITION OF VIVOSTAT A/S

/Not for distribution to U.S. news wire services or for dissemination in the United States /

  • Binding Share Purchase Agreement to purchase 100% of Denmark -based Vivostat A/S (" Vivostat ").
  • Vivostat has a unique system for on-site preparation and application of autologous concentrated fibrin and platelet enriched fibrin sealants for use in post-surgical procedures.
  • Used in over 200,000 surgical procedures, Vivostat's system has peer-reviewed evidence of zero rejection and infection rates.
  • Vivostat has been profitable for the last 3 years and currently generates revenues of approximately €3,600,000 per year with a 60% gross profit margin.
  • Vivostat is currently only actively marketed in six European countries representing less than 10% of its total addressable market.
  • Transaction is expected to close on or before March 15, 2024 , subject to receipt of applicable approvals, including of the TSX Venture Exchange (" TSX-V ") and satisfaction of conditions.

Principal Technologies Inc. (the " Company " or " Principal ") (TSXV: PTEC) (FSE: J07), is pleased to announce that as at February 6, 2024 it entered into an arm's length binding Share Purchase Agreement (" SPA ") to acquire (the " Acquisition ") 100% of the equity interests of Vivostat, a 23-year-old Danish company which uses a unique autologous fibrin sealant solution for post-surgical use.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
PRINCIPAL TECHNOLOGIES CLOSES THIRD AND FINAL TRANCHE OF OVERSUBSCRIBED PRIVATE PLACEMENT

PRINCIPAL TECHNOLOGIES CLOSES THIRD AND FINAL TRANCHE OF OVERSUBSCRIBED PRIVATE PLACEMENT

/Not for distribution to U.S. news wire services or for dissemination in the United States /

Principal Technologies Inc. (the " Company ") (TSXV: PTEC ), is pleased to announce the closing of the third and final tranche (" Tranche 3 ") of its previously announced non-brokered private placement (the " Offering "). The Company issued an additional 833,333 common shares (the " Shares ") at $0.15 per Share for gross proceeds of $124,999.95 bringing the total offering to 9,993,166 Shares for aggregate gross proceeds of $1,498,974.95 when combined with the two previous closings, subject to final approval from the TSX Venture Exchange (" TSXV "). For more information on the Offering, see the Company's news releases dated October 6, 2023 November 21, 2023 and December 21, 2023 .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
PRINCIPAL TECHNOLOGIES CLOSES SECOND TRANCHE AND ANNOUNCES UPSIZE OF OVERSUBSCRIBED PRIVATE PLACEMENT

PRINCIPAL TECHNOLOGIES CLOSES SECOND TRANCHE AND ANNOUNCES UPSIZE OF OVERSUBSCRIBED PRIVATE PLACEMENT

 Principal Technologies Inc. (the " Company ") (TSXV: PTEC), is pleased to announce the closing of the second tranche (" Tranche 2 ") of its previously announced non-brokered private placement (the " Offering "). Under Tranche 2 of the Offering, the Company issued 6,823,333 common shares (the " Shares ") at $0.15 per Share for gross proceeds of $1,023,500 . The total raised under the Offering to date is $1,373,975 .

The Company also announces that it has increased the size of the Offering, as previously described in the Company's news releases dated October 6, 2023 and November 21, 2023 . The Company now intends to issue up to 10,700,000 Shares at a price of $0.15 per Share for total gross proceeds of approximately $1,600,000 subject to final approval from the TSX Venture Exchange (" TSXV "). The Company first announced the Offering for up to 6,000,000 common shares of the Company for aggregate gross proceeds of up to $900,000 .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
PRINCIPAL TECHNOLOGIES ANNOUNCES CLOSING OF FIRST TRANCH OF PRIVATE PLACEMENT

PRINCIPAL TECHNOLOGIES ANNOUNCES CLOSING OF FIRST TRANCH OF PRIVATE PLACEMENT

Principal Technologies Inc. (the " Company ") (TSXV: PTEC), is pleased to announce the closing of the first tranche (" Tranche 1 ") of its previously announced non-brokered private placement (the " Offering ") issuing a total of 2,336,500 common shares (the " Shares ") at $0.15 per Share for gross proceeds of $350,475.00 . The Company has received additional offers to participate in the Offering, and closing of the second tranche is anticipated in early December.

The Company also announces it has received approval from the TSXV Venture Exchange (" TSXV ") for an extension to close the Offering on, or before, December 21, 2023 . The Company first announced the Offering on October 6, 2023 for up to 6,000,000 common shares of the Company for aggregate gross proceeds of up to $900,000 .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

/C O R R E C T I O N -- Nanalysis Scientific Corp./

In the news release, Nanalysis Announces Full Year 2023 Conference Call, issued 11-Apr-2024 by Nanalysis Scientific Corp. over CNW, we are advised by the company that the Hosting Call and European Q&A Session date mentioned should read " Monday, April 29th and Tuesday, April 30th respectively" rather than " Thursday April 25th and Friday April 26th respectively" as originally issued inadvertently. The complete, corrected release follows:

Nanalysis Announces Full Year 2023 Conference Call

Hosting Call at 5:00 pm ET on Monday , April 29th

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
Nextech3D.ai Selects AWS as its Primary Cloud Provider to Drive Innovation in the 3D Modeling For Ecommerce Industry With Cutting Edge AI

Nextech3D.ai Selects AWS as its Primary Cloud Provider to Drive Innovation in the 3D Modeling For Ecommerce Industry With Cutting Edge AI

Leading 3D Modeling Supplier uses AWS's generative AI and machine learning capabilities to accelerate its technology

Nextech3D.ai (OTCQX:NEXCF)(CSE:NTAR)(FSE:EP2), a patented 2D-3D Generative AI-Powered 3D model supplier for Amazon, Miele, P&G, Kohls, Wesfarmers Group "Bunnings" and other major e-commerce retailers has selected Amazon Web Services (AWS), an Amazon.com company (NASDAQ:AMZN), as its cloud provider for its 3D modeling hosting services and AI service provider. Nextech3D.ai will also host its dozens of AI Machine learning applications to the world's leading cloud. Using Amazon Bedrock, a service that makes multiple foundation models available via an API, Nextech3D.ai can build experimental generative AI applications to improve productivity across all business lines, including customer service, finance, human resources, and sales. The AI factory allows the company to efficiently use analytics and ML to develop and deploy churn prediction and next best-offer systems to drive customer engagement

News Provided by ACCESSWIRE IA via QuoteMedia

Keep reading...Show less
Nextech3D.ai Receives Notice From USPTO to be Granted Patent for CAD 3D Model Part Assembly & Segmentation

Nextech3D.ai Receives Notice From USPTO to be Granted Patent for CAD 3D Model Part Assembly & Segmentation

Company Expanding its Portfolio of AI Patents for 3D Modeling and CAD

Nextech3D.ai (OTCQX:NEXCF)(CSE:NTAR)(FSE:EP2), a patented 2D-3D Generative AI-Powered 3D model supplier for Amazon, Miele, P&G, Kohls, Wesfarmers Group "Bunnings" (Australia's largest listed company) and other major e-commerce retailers is excited to announce that U.S. Patent and Trademark Office (USPTO) has informed of their decision to issue a patent for its technology to assemble and segment parts for 3D CAD files so that each 3D part can be textured individually. This technology is currently having success and being used on the Toggle3D.ai Platform. This is another patent which the Company believes is pivotal to Nextech3D.ai's artificial intelligence technology stack as it builds a moat around its 3D model making for ecommerce business with industry expertise and intellectual property; which includes its GPT AI powered 3D model generation. This patent approval reinforces and validates Nextech3D.ai's commitment to increasing shareholder value by investing in 3D-AI & GPT patents and solutions

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
Nextech3D.ai Expands Offering to Ecommerce Imagery: Unveils Cutting-Edge 3D Model-AI Photo Rendering Services, Transforming 2D Photos into Dynamic Product Visuals

Nextech3D.ai Expands Offering to Ecommerce Imagery: Unveils Cutting-Edge 3D Model-AI Photo Rendering Services, Transforming 2D Photos into Dynamic Product Visuals

New ecommerce expansion with AI 3D-Photography Tools

Nextech3D.ai (OTCQX:NEXCF)(CSE:NTAR)(FSE:EP2), a patented 2D-3D Generative AI-Powered 3D model supplier (Patent #11,948,248) for Amazon, Miele, P&G, Kohls, Wesfarmers Group ``Bunnings" (Australia's largest listed company) and other major e-commerce retailers is adding Digital Photography and dynamic product visuals as part of its 3D model offerings. Now every 3D model that Nextech3D.ai creates will have stunning 2K, 4K, or even 8K photos to go with it for its ecommerce customers. This AI tool is expected to drive significant revenue for the company as each product listed for sale on an ecommerce platform requires a minimum of six 2D photos for listing, this offering allows the company to capitalize on this demand for 2D high res images while simultaneously increases the value of its 3D modeling business as it represents the all-in-one solutions for ecommerce sellers that sell on Amazon, Shopify and other platforms. The company has already signed up 10 existing customers for its digital photography offering representing over 6000+digital photos and will be offering it both as part of a 3D model bundle as well as a stand alone product offering for people that already have a 3D model opening up the ecommerce imagery market to the company. The company's analysis shows that creating and rendering 3D models is more cost-effective than traditional product photography, especially for products that are expensive to produce or difficult to photograph in real life. Once a 3D model is created, it can be easily manipulated and rendered from different angles without the need for physical prototypes or multiple photoshoots

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
Aether Global Provides Update on Management Cease Trade Order

Aether Global Provides Update on Management Cease Trade Order

(TheNewswire)

Aether Global Innovations Corp.

Vancouver, B.C. TheNewswire - April 17, 2024 Aether Global Innovations Corp. (CSE:AETH) (OTC:AETHF) (Frankfurt:4XA) (WKN#A2N8RH), a leader in drone management and automation, is providing this update on the status of a management cease trade order (the "MCTO") granted on April 3, 2024 by the British Columbia Securities Commission under National Policy 12-203 - Management Cease Trade Order ("NP 12-203").

News Provided by TheNewsWire via QuoteMedia

Keep reading...Show less
NEO Battery Materials Appoints Renowned Battery Industry Pioneer Mr. Ricky Lee as Lead Managerial Advisor

NEO Battery Materials Appoints Renowned Battery Industry Pioneer Mr. Ricky Lee as Lead Managerial Advisor

T S X V : NBM ) ( OTC: NBMFF )

NEO Battery Materials Ltd. (" NEO " or the " C o mpan y "), a low-cost silicon anode materials developer that enables longer-running, rapid-charging lithium-ion batteries, is pleased to appoint Mr. Ricky Lee, a renowned battery industry pioneer, as the Lead Managerial Advisor. Mr. Ricky Lee is a 35-year battery and energy industry executive with substantial experience with battery material and cell design, mass-production technology, and equipment & process development at globally distinguished companies.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Principal Technologies

Principal Technologies Investor Kit

  • Corporate info
  • Insights
  • Growth strategies
  • Upcoming projects

GET YOUR FREE INVESTOR KIT

Latest Press Releases

Related News

×